Combination of Obinutuzumab and Venetoclax in Relapsed or Refractory DLBCL
Clinical trial NCT02987400 · COMPLETED
Trial details
- NCT number
- NCT02987400
- Sponsor
- Arbeitsgemeinschaft medikamentoese Tumortherapie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-04
- Primary completion
- 2021-10-19
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.